Skip to content

Corcept Therapeutics CORT Payments to Acquire Property, Plant, and Equipment

Payments to Acquire Property, Plant, and Equipment at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$19.7M+41.7%
Cytokinetics logo
CytokineticsCYTK
Summit Therapeutics logo
Summit TherapeuticsSMMT
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$164.9M+4.9%
Gross profit$162.0M+4.7%
Operating income-$49.6M-1,552%
Net income-$31.8M-255%
EPS (diluted)-$0.30-276%

Balance sheet

See full
Cash & equivalents$110.0M+21.1%
Total debt$9.6M+41.0%
Total equity$638.0M-6.6%
Total assets$814.9M-3.7%

Cash flow

See full
Operating cash flow-$16.8M-452%
CapEx$201.0K+93.3%
Free cash flow-$17.0M-464%

Valuation

See full
Market cap$8.58B-64.4%
Enterprise value$8.48B-65.0%
P/E181.2×+1.3×
P/S11.2×-24.0×

Profitability

See full
Gross margin98.3%-0.2pp
Operating margin-1.1%-17.2pp
Net margin6.2%-13.4pp
FCF margin15.6%-10.2pp

Returns & leverage

See full
Return on equity7.2%-14.6pp
Debt / equity0.0×
Current ratio2.9×-0.2×

Where this comes from

Reported directly by Corcept Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Corcept Therapeutics's payments to acquire property, plant, and equipment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Corcept Therapeutics's payments to acquire property, plant, and equipment?
Corcept Therapeutics (CORT) reported payments to acquire property, plant, and equipment of $201K in Q1 2026.
How has Corcept Therapeutics's payments to acquire property, plant, and equipment changed year-over-year?
Corcept Therapeutics's payments to acquire property, plant, and equipment increased by 93.3% year-over-year, from $104K to $201K.
What is the long-term trend for Corcept Therapeutics's payments to acquire property, plant, and equipment?
Over 4 years (2021 to 2025), Corcept Therapeutics's payments to acquire property, plant, and equipment has grown at a -18.1% compound annual growth rate (CAGR), from $469K to $211K.